Cargando…

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

BACKGROUND: In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving a potential window for vertical transmission. Insights into HBV seroprevalence in the vulnerable HIV-infected group are important to drive improvements in surveillance, treatment and prevention. OBJECTIVE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jooste, Pieter, van Zyl, Anriette, Adland, Emily, Daniels, Samantha, Hattingh, Louise, Brits, Alethea, Wareing, Susan, Goedhals, Dominique, Jeffery, Katie, Andersson, Monique, Goulder, Philip, Matthews, Philippa C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5142290/ https://www.ncbi.nlm.nih.gov/pubmed/27838494 http://dx.doi.org/10.1016/j.jcv.2016.10.017

Ejemplares similares

HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model
por: McNaughton, Anna L., et al.
Publicado: (2019)

PARV4 prevalence, phylogeny, immunology and coinfection with HIV, HBV and HCV in a multicentre African cohort
por: Sharp, Colin P., et al.
Publicado: (2017)

Paediatric PARV4 infection in South Africa: relationship to age, maternal PARV4 status, and HIV infection
por: Matthews, Philippa, et al.
Publicado: (2014)

Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection
por: Mori, Masahiko, et al.
Publicado: (2015)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

Human Parvovirus 4 Infection among Mothers and Children in South Africa
por: Matthews, Philippa C., et al.
Publicado: (2015)

Prevalence and Characteristics of Hepatitis B Virus (HBV) Coinfection among HIV-Positive Women in South Africa and Botswana
por: Matthews, Philippa C., et al.
Publicado: (2015)

Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era
por: Adland, Emily, et al.
Publicado: (2015)

Recovery of effective HIV-specific CD4(+) T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia
por: Adland, Emily, et al.
Publicado: (2018)

Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort
por: Maponga, Tongai G., et al.
Publicado: (2020)

A systematic review of hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: A call for urgent action
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts
por: Brown, Robin, et al.
Publicado: (2022)

HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes
por: Ditse, Zanele, et al.
Publicado: (2018)

Characterizing the epidemiology and interaction between HIV-1 and HBV co-infection in South Africa
por: Matthews, Philippa C, et al.
Publicado: (2014)

Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations
por: Malik, Amna, et al.
Publicado: (2017)

Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort
por: Adland, Emily, et al.
Publicado: (2018)

Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
por: Mofokeng, Nombuyiselo, et al.
Publicado: (2023)

Strong sex bias in elite control of paediatric HIV infection
por: Vieira, Vinicius A., et al.
Publicado: (2019)

Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South Africa
por: Downs, Louise O., et al.
Publicado: (2020)

Co-Operative Additive Effects between HLA Alleles in Control of HIV-1
por: Matthews, Philippa C., et al.
Publicado: (2012)

A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review
por: Mokaya, Jolynne, et al.
Publicado: (2018)

Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection
por: Chowdhury, Fazle Rabbi, et al.
Publicado: (2021)

Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia
por: Tamandjou Tchuem, Cynthia Raissa, et al.
Publicado: (2020)

FAIR data needed to liberate hepatitis B virus (HBV) from the catch-22 of neglect
por: Matthews, Philippa C
Publicado: (2019)

Risk of Reactivation of Hepatitis B Virus (HBV) and Tuberculosis (TB) and Complications of Hepatitis C Virus (HCV) Following Tocilizumab Therapy: A Systematic Review to Inform Risk Assessment in the COVID-19 Era
por: Campbell, Cori, et al.
Publicado: (2021)

HLA-A is a Predictor of Hepatitis B e Antigen Status in HIV-Positive African Adults
por: Matthews, Philippa C., et al.
Publicado: (2016)

P73. Functional characterisation of HBV-specific T cell receptors for redirection of T cells against HBV infected hepatocytes
por: Krebs, K, et al.
Publicado: (2014)

Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV
por: Vieira, Vinicius A., et al.
Publicado: (2022)

Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas
por: Amaddeo, Giuliana, et al.
Publicado: (2015)

Hepatitis B virus resistance to tenofovir: fact or fiction? A systematic literature review and structural analysis of drug resistance mechanisms
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Characterisation of K(+) Channels in Human Fetoplacental Vascular Smooth Muscle Cells
por: Brereton, Melissa F., et al.
Publicado: (2013)

Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era
por: Vieira, Vinicius A., et al.
Publicado: (2022)

PhyloPi: An affordable, purpose built phylogenetic pipeline for the HIV drug resistance testing facility
por: Bester, Phillip Armand, et al.
Publicado: (2019)

Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences
por: McNaughton, Anna L., et al.
Publicado: (2020)

Role of HIV-specific CD8(+) T cells in pediatric HIV cure strategies after widespread early viral escape
por: Leitman, Ellen M., et al.
Publicado: (2017)

The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection
por: Pley, Caitlin M, et al.
Publicado: (2021)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations
por: Mokaya, Jolynne, et al.
Publicado: (2021)

Seroepidemiologic Survey of Crimean-Congo Hemorrhagic Fever Virus in Selected Risk Groups, South Africa
por: Vawda, Sabeehah, et al.
Publicado: (2018)

HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa
por: Maponga, Tongai Gibson, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0gv0a1lsbj9tjjr8jf5olt4fjo